Deepak Nitrite's Board Approves Major Project for Bisphenol A Manufacturing
The Board of Directors of Deepak Chem Tech Limited (DCTL), a wholly owned subsidiary of Deepak Nitrite Limited, has approved an ambitious project aimed at manufacturing Bisphenol A (BPA). This new capacity will stand up to 240 KTA and is backed by an investment totaling around ₹2,500 Crores, which encompasses the related greenfield infrastructure capital expenditure.The approval for the BPA facility allows Deepak Nitrite Limited to significantly expand its integrated manufacturing capabilities across the chemical value chain. The project investment is subject to confirmation upon the completion of detailed engineering and will be financed through a mix of debt and equity.
Expanding Integrated Chemical Platform
The establishment of the Bisphenol A capacity complements DCTL’s existing strategic projects. The Board has previously cleared the setting up of India's first Polycarbonate resin manufacturing plant, which leverages Trinseo technology and associated asset acquisition, along with a Phenol Acetone manufacturing plant.With the addition of BPA to its portfolio, Deepak is moving toward establishing a highly integrated manufacturing platform. This platform spans the entire value chain—from Cumene through to Phenol & Acetone, Bisphenol A (BPA), and Polycarbonate resin, including subsequent downstream compounding activities.
Beyond fulfilling captive requirements for the production of Polycarbonate resins, the new BPA facility positions Deepak to actively participate in the rapidly growing Indian market segment for Bisphenol A used in the manufacturing of Epoxy resins.
DEEPAKNTR Stock Price Movement
Deepak Nitrite Limited's equity edged higher today, closing out the trading session at ₹1717.7 after gaining 0.36%. The shares traded within a range of ₹1710.4 and ₹1753.5, with 281,164 shares accounted for in today's movement.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.